CN Patent

CN101252837A — 用二氢吡啶类钙通道阻断剂和Omega-3脂肪酸及其组合产品的治疗

Assigned to Reliant Pharmaceuticals Inc · Expires 2008-08-27 · 18y expired

What this patent protects

一种或多种二氢吡啶类钙通道阻断剂与omega－3脂肪酸混合物的组合，施用该组合的方法，以及该组合的单位剂型。

USPTO Abstract

一种或多种二氢吡啶类钙通道阻断剂与omega－3脂肪酸混合物的组合，施用该组合的方法，以及该组合的单位剂型。

Drugs covered by this patent

Patent Metadata

Patent number
CN101252837A
Jurisdiction
CN
Classification
—
Expires
2008-08-27
Drug substance claim
No
Drug product claim
No
Assignee
Reliant Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.